229 related articles for article (PubMed ID: 30182387)
1. Altered excitability and exocytosis in chromaffin cells from the R6/1 mouse model of Huntington's disease is linked to over-expression of mutated huntingtin.
Martínez-Ramírez C; Baraibar AM; Nanclares C; Méndez-López I; Gómez A; Muñoz MP; de Diego AMG; Gandía L; Casarejos MJ; García AG
J Neurochem; 2018 Nov; 147(4):454-476. PubMed ID: 30182387
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction in chromaffin cells from the R6/1 mouse model of Huntington's disease: Impact on exocytosis and calcium current regulation.
Fernández A; Martínez-Ramírez C; Gómez A; de Diego AMG; Gandía L; Casarejos MJ; García AG
Neurobiol Dis; 2023 Apr; 179():106046. PubMed ID: 36806818
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Exocytosis in Sympathoadrenal Chromaffin Cells from Mouse Models of Neurodegenerative Diseases.
de Diego AMG; Ortega-Cruz D; García AG
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178443
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice.
Johnson MA; Villanueva M; Haynes CL; Seipel AT; Buhler LA; Wightman RM
J Neurochem; 2007 Dec; 103(5):2102-10. PubMed ID: 17868298
[TBL] [Abstract][Full Text] [Related]
5. Depressed excitability and ion currents linked to slow exocytotic fusion pore in chromaffin cells of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Calvo-Gallardo E; de Pascual R; Fernández-Morales JC; Arranz-Tagarro JA; Maroto M; Nanclares C; Gandía L; de Diego AM; Padín JF; García AG
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C1-19. PubMed ID: 25377090
[TBL] [Abstract][Full Text] [Related]
6. Forty years of the adrenal chromaffin cell through ISCCB meetings around the world.
Maneu V; Borges R; Gandía L; García AG
Pflugers Arch; 2023 Jun; 475(6):667-690. PubMed ID: 36884064
[TBL] [Abstract][Full Text] [Related]
7. Huntingtin-associated protein 1 regulates exocytosis, vesicle docking, readily releasable pool size and fusion pore stability in mouse chromaffin cells.
Mackenzie KD; Duffield MD; Peiris H; Phillips L; Zanin MP; Teo EH; Zhou XF; Keating DJ
J Physiol; 2014 Apr; 592(7):1505-18. PubMed ID: 24366265
[TBL] [Abstract][Full Text] [Related]
8. Altered exocytosis in chromaffin cells from mouse models of neurodegenerative diseases.
de Diego AMG; García AG
Acta Physiol (Oxf); 2018 Oct; 224(2):e13090. PubMed ID: 29742321
[TBL] [Abstract][Full Text] [Related]
9. Extracellular and intracellular sphingosine-1-phosphate distinctly regulates exocytosis in chromaffin cells.
Jiang ZJ; Delaney TL; Zanin MP; Haberberger RV; Pitson SM; Huang J; Alford S; Cologna SM; Keating DJ; Gong LW
J Neurochem; 2019 Jun; 149(6):729-746. PubMed ID: 30963576
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis.
Larsen KE; Schmitz Y; Troyer MD; Mosharov E; Dietrich P; Quazi AZ; Savalle M; Nemani V; Chaudhry FA; Edwards RH; Stefanis L; Sulzer D
J Neurosci; 2006 Nov; 26(46):11915-22. PubMed ID: 17108165
[TBL] [Abstract][Full Text] [Related]
11. Dual action of leptin on rest-firing and stimulated catecholamine release via phosphoinositide 3-kinase-driven BK channel up-regulation in mouse chromaffin cells.
Gavello D; Vandael D; Gosso S; Carbone E; Carabelli V
J Physiol; 2015 Nov; 593(22):4835-53. PubMed ID: 26282459
[TBL] [Abstract][Full Text] [Related]
12. Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
Smith R; Petersén A; Bates GP; Brundin P; Li JY
Neurobiol Dis; 2005 Dec; 20(3):673-84. PubMed ID: 15967669
[TBL] [Abstract][Full Text] [Related]
13. Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.
Calorio C; Gavello D; Guarina L; Salio C; Sassoè-Pognetto M; Riganti C; Bianchi FT; Hofer NT; Tuluc P; Obermair GJ; Defilippi P; Balzac F; Turco E; Bett GC; Rasmusson RL; Carbone E
J Physiol; 2019 Mar; 597(6):1705-1733. PubMed ID: 30629744
[TBL] [Abstract][Full Text] [Related]
14. Faster kinetics of quantal catecholamine release in mouse chromaffin cells stimulated with acetylcholine, compared with other secretagogues.
Calvo-Gallardo E; López-Gil Á; Méndez-López I; Martínez-Ramírez C; Padín JF; García AG
J Neurochem; 2016 Dec; 139(5):722-736. PubMed ID: 27649809
[TBL] [Abstract][Full Text] [Related]
15. The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis.
Björkqvist M; Fex M; Renström E; Wierup N; Petersén A; Gil J; Bacos K; Popovic N; Li JY; Sundler F; Brundin P; Mulder H
Hum Mol Genet; 2005 Mar; 14(5):565-74. PubMed ID: 15649949
[TBL] [Abstract][Full Text] [Related]
16. Tight mitochondrial control of calcium and exocytotic signals in chromaffin cells at embryonic life.
Vestring S; Fernández-Morales JC; Méndez-López I; C Musial D; G de Diego AM; Padín JF; G García A
Pflugers Arch; 2015 Dec; 467(12):2589-601. PubMed ID: 26254593
[TBL] [Abstract][Full Text] [Related]
17. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
Dufour BD; McBride JL
Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
[TBL] [Abstract][Full Text] [Related]
18. Ca(2+)-dependent activator protein for secretion is critical for the fusion of dense-core vesicles with the membrane in calf adrenal chromaffin cells.
Elhamdani A; Martin TF; Kowalchyk JA; Artalejo CR
J Neurosci; 1999 Sep; 19(17):7375-83. PubMed ID: 10460244
[TBL] [Abstract][Full Text] [Related]
19. The quantal catecholamine release from mouse chromaffin cells challenged with repeated ACh pulses is regulated by the mitochondrial Na
López-Gil A; Nanclares C; Méndez-López I; Martínez-Ramírez C; de Los Rios C; Padín-Nogueira JF; Montero M; Gandía L; García AG
J Physiol; 2017 Mar; 595(6):2129-2146. PubMed ID: 27982456
[TBL] [Abstract][Full Text] [Related]
20. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.
Sebastianutto I; Cenci MA; Fieblinger T
Neurobiol Dis; 2017 Sep; 105():117-131. PubMed ID: 28578004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
